In this study we show, for the first time, that cultured SCLC cells respond to IL-27 by activating STAT1, and to a lesser extent STAT3, tyrosine phosphorylation and by up-regulating HLA class I surface molecule expression. The gene discussed is STAT3; the disease is small cell lung carcinoma.